Healthcare executive focused on commercial strategy, specialty pharmacy, diabetes care, digital health, and patient engagement.
Christine Sawicki is a healthcare executive, registered pharmacist, and Lean Six Sigma Master Black Belt. Her work focuses on connecting clinical insight, commercial strategy, technology, and patient support to improve access and care delivery.
Read executive bio
Christine Sawicki is a healthcare executive, registered pharmacist, and Lean Six Sigma Master Black Belt with experience across specialty pharmacy, PBM strategy, diabetes care, digital health, patient engagement, and commercial healthcare solutions.
Christine currently serves as Vice President, Commercial Solutions Management at CCS, where her work focuses on helping people living with diabetes access the technologies, medications, supplies, education, and clinical support they need to manage their condition. In this role, she works across commercial strategy, chronic care innovation, health plan relationships, provider partnerships, employer solutions, and patient support models.
Her career has centered on a practical question: how do we make complex healthcare systems work better for patients, clients, clinicians, and organizations? That focus has shaped her work in specialty pharmacy, pharmacy benefit management, digital care delivery, clinical program development, and product commercialization.
Before joining CCS, Christine held leadership roles at CVS Health and CVS Caremark, including work in PBM marketing strategy, specialty pharmacy clinical programs, digital prescription platforms, secure patient messaging, and client-facing growth strategy. Her work has included building clinical and commercial narratives for large-scale healthcare clients, supporting specialty product launches, and helping translate complex clinical services into clear, usable value for clients and patients.
Christine is also an inventor on two U.S. patents: one related to secure patient messaging and another related to intelligent medication monitoring systems. These patents reflect a consistent theme in her work: using technology in a practical way to improve care delivery, communication, adherence, and patient support.
Her clinical and business background gives her a broad view of healthcare. She earned her MBA from Anna Maria College, a Bachelor of Science in Pharmacy from Massachusetts College of Pharmacy, and a Bachelor of Arts in Chemistry from Assumption University. She is a registered pharmacist, a Certified Lean Six Sigma Master Black Belt through Villanova University, and has additional training in pharmacoeconomic analysis, oncology, and diabetes care.
In addition to her executive work, Christine serves as adjunct faculty at Assumption University in the MBA and Health Advocacy programs, where she teaches healthcare strategy, innovation, and applied health advocacy. She brings real-world healthcare experience into the classroom and helps students understand how policy, business, clinical care, and patient experience intersect.
Christine’s work is grounded in relationships, service, and execution. She is known for connecting people, simplifying complex healthcare issues, and building programs that are practical, scalable, and tied to real patient and business needs.
Outside of her professional roles, Christine has a long history of community involvement, including more than 35 years as a musician and chorister in the Diocese of Worcester and St. Paul’s Cathedral Choir. Her community work reflects the same values that show up in her professional life: commitment, service, discipline, and care for others.
Christine’s professional focus includes commercial healthcare strategy, specialty pharmacy, diabetes technology and care delivery, patient engagement, digital health, PBM strategy, clinical program design, and healthcare innovation.
Currently leading commercial strategy at CCS (Chronic Care Solutions), where my focus is connecting patients living with diabetes to the right technologies, medications, and clinical support — and building the health plan, provider, and employer partnerships that make that access possible. Inventor of two U.S.-patented technologies with proven commercial impact at scale.
Executive-level fluency across PBM operations, specialty pharmacy clinical programs, and value-based contract design. Builder of performance guarantee frameworks, clinical outcome narratives, and sales enablement tools for multi-billion-dollar client opportunities. Deep experience in product commercialization and transformational product launches in oncology, rheumatology, multiple sclerosis, psoriasis, and hemophilia — translating complex specialty therapeutics into compelling market strategies that accelerate adoption and improve patient access.
Currently leading PBM marketing strategy at CVS Caremark — translating complex benefit and coverage solutions into simplified stories that drive client growth and retention. Focused on measurable brand impact and sales enablement.
Advanced Pharmacoeconomic Analysis certification (USC & Amgen). Track record deploying data analytics strategy for predictive patient care, clinical decision support, and performance guarantee frameworks that reduce financial risk while improving outcomes.
Over a decade leading clinical and digital innovation within CVS Specialty — one of the nation's largest specialty pharmacy divisions — across the most complex and high-cost therapeutic areas. Built and scaled patient engagement platforms, digital adherence solutions, and clinical program frameworks for patients managing oncology, rare disease, autoimmune, and other specialty conditions where medication complexity and adherence are critical to outcomes.
Invented a patented secure clinical messaging platform (US Patent #11,387,005) specifically designed for specialty patients — achieving industry-leading engagement in populations where standard digital tools fail. Developed and deployed predictive analytics and clinical decision support tools that optimized care pathways for high-acuity patients and reduced financial risk through performance guarantee frameworks.
Established the first ASHP-accredited Specialty Innovation PGY1 Pharmacy Residency — architecting a lasting talent pipeline that equips the next generation of pharmacists to lead at the frontier of specialty care, digital health innovation, and clinical excellence, institutionalizing the connection between pharmacy practice and transformational outcomes. Led innovation for design, technology, and pharmacist-led services to define the future of pharmacy. Led enterprise-wide omnichannel strategy achieving over 65% digital engagement and 97% patient opt-in across specialty therapy management programs — results that set new industry benchmarks.
Deep therapeutic knowledge across oncology (including CML and oral chemotherapy adherence), autoimmune, rare disease, and complex chronic conditions — combined with the commercial and digital strategy expertise to translate clinical insight into scalable solutions that demonstrably improve outcomes and generate enterprise value.
Deep experience navigating the unique commercial and clinical complexities of rare disease — where patient populations are small, diagnostic journeys are long, and access barriers are profound. Built and scaled specialty pharmacy programs and digital engagement platforms for patients managing conditions where standard care pathways don't apply. Expertise in designing high-touch, clinically informed support models that address the distinct needs of rare disease patients, caregivers, and the multidisciplinary teams that serve them.
Specialized understanding of the orphan drug landscape — including the regulatory, reimbursement, and market access dynamics that govern ultra-rare conditions. Experience supporting orphan product commercialization within the specialty pharmacy channel, where payer coverage complexity, prior authorization burden, and limited clinical precedent create significant access challenges. Skilled at building the evidence, advocacy, and patient support infrastructure that enables orphan therapies to reach the patients who need them.
Gene therapy represents one of the most complex and consequential frontiers in modern medicine — and one of the most demanding commercialization challenges in the specialty pharmacy landscape. With experience in hemophilia and other rare conditions where gene therapies are transforming the standard of care, I bring a grounded understanding of the clinical, operational, and financial infrastructure required to support one-time curative therapies at scale.
From site of care logistics and cold-chain distribution to long-term outcomes tracking, value-based contracting, and payer engagement for therapies with multi-million-dollar price points — I understand what it takes to build the commercial and patient support ecosystems that give gene therapies the best chance of reaching patients and delivering on their promise. An emerging area of strategic focus as these modalities move from clinical trials into mainstream specialty pharmacy.
For advisory work, speaking, healthcare strategy, digital health, specialty pharmacy, or diabetes care initiatives, please reach out directly by email or LinkedIn.
One-page professional bio · PDF
The professional bio download remains available if the PDF is uploaded with the filename Christine_Sawicki_Bio.pdf.